Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Azizi

Showing results (161-170 of 267) with videos related to

Pageof 27
Sort By:
Journal of Hypertension|March 19, 2019
A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertensionMichel Azizi, Pierre-Yves Courand, Thierry Denolle, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicityGeneviève Nguyen, Anne Blanchard, Emmanuel Curis, et al.
Cytotherapy|November 28, 2013
Forearm ischemia decreases endothelial colony-forming cell angiogenic potentialLaetitia Mauge, Florence Sabatier, Pierre Boutouyrie, et al.
Cardiovascular Research|July 16, 2021
Erratum to: Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of EvidenceReinhold Kreutz, Engi Abd El-Hady Algharably, Michel Azizi, et al.
Cardiovascular Research|April 16, 2020
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19Reinhold Kreutz, Engi Abd El-Hady Algharably, Michel Azizi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Changes in blood pressure after crossover to ultrasound renal denervationMichael J Bloch, Michel Azizi, Ajay J Kirtane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.
JACC. Cardiovascular Imaging|September 20, 2020
Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic ResonanceAlban Redheuil, Anne Blanchard, Helena Pereira, et al.
Journal of Hypertension|September 8, 2006
Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjectsGian Paolo Rossi, Stefano Taddei, Lorenzo Ghiadoni, et al.
Pharmacoeconomics - Open|April 16, 2025
Cost-Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The NetherlandsRod S Taylor, Kaylie Metcalfe, Antoine Cremer, et al.
Pageof 27

Showing results (161-170 of 267) with videos related to

Sort By:
Pageof 27
Journal of Hypertension|March 19, 2019
A pilot double-blind randomized placebo-controlled crossover pharmacodynamic study of the centrally active aminopeptidase A inhibitor, firibastat, in hypertensionMichel Azizi, Pierre-Yves Courand, Thierry Denolle, et al.
Hypertension (Dallas, Tex. : 1979)|November 13, 2013
Plasma soluble (pro)renin receptor is independent of plasma renin, prorenin, and aldosterone concentrations but is affected by ethnicityGeneviève Nguyen, Anne Blanchard, Emmanuel Curis, et al.
Cytotherapy|November 28, 2013
Forearm ischemia decreases endothelial colony-forming cell angiogenic potentialLaetitia Mauge, Florence Sabatier, Pierre Boutouyrie, et al.
Cardiovascular Research|July 16, 2021
Erratum to: Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19: European Society of Hypertension COVID-19 Task Force Review of EvidenceReinhold Kreutz, Engi Abd El-Hady Algharably, Michel Azizi, et al.
Cardiovascular Research|April 16, 2020
Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19Reinhold Kreutz, Engi Abd El-Hady Algharably, Michel Azizi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 8, 2025
Changes in blood pressure after crossover to ultrasound renal denervationMichael J Bloch, Michel Azizi, Ajay J Kirtane, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|August 1, 2022
Durability of blood pressure reduction after ultrasound renal denervation: three-year follow-up of the treatment arm of the randomised RADIANCE-HTN SOLO trialFlorian Rader, Ajay J Kirtane, Yale Wang, et al.
JACC. Cardiovascular Imaging|September 20, 2020
Aldosterone-Related Myocardial Extracellular Matrix Expansion in Hypertension in Humans: A Proof-of-Concept Study by Cardiac Magnetic ResonanceAlban Redheuil, Anne Blanchard, Helena Pereira, et al.
Journal of Hypertension|September 8, 2006
Tissue kallikrein gene polymorphisms induce no change in endothelium-dependent or independent vasodilation in hypertensive and normotensive subjectsGian Paolo Rossi, Stefano Taddei, Lorenzo Ghiadoni, et al.
Pharmacoeconomics - Open|April 16, 2025
Cost-Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The NetherlandsRod S Taylor, Kaylie Metcalfe, Antoine Cremer, et al.
Pageof 27